LLY240628C910000
- 0.20
- 0.000.00%
Eli Lilly and Co Newsroom
A Harvard study shows a link between weight loss drug Ozempic and rare vision loss, causing a nearly 5% drop in novo-nordisk a/s stocks.
Some doctors have pointed out that there is currently no evidence to prove a direct causal relationship between drug use and eye complications, as some cases only appear after several months of medication.
US stocks closing | S&P, Nasdaq hit new highs again! Tesla rose nearly 35% in seven days, and Nvidia rose more than 4.5% overnight.
S&P has reached a new high for two consecutive days, NASDAQ has reached a new high for three consecutive days, and Dow's intraday decline has significantly narrowed. Google, Apple, Microsoft, Taiwan Semiconductor in the US stock market have all reached new highs. Tesla has risen by 35% in seven days, and the chip stock index has risen by nearly 2%.
Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$8.1 Million in Common Stock
$Eli Lilly and Co(LLY.US)$ 10% Shareholder LILLY ENDOWMENT INC sold 8,848 shares of common stock on Jul 3, 2024 at an average price of $915.309 for a total value of $8.1 million.Source: Announcement W
Lilly's New Alzheimer's Drug Could Generate $7.1B in Sales: Analyst
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June's sharply lower-than-expected services sector activ
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
On Tuesday, the FDA approved Eli Lilly and Co's (NYSE:LLY) Kisunla (donanemab) once-monthly injection for IV infusion) for adults with early symptomatic Alzheimer's disease.Once-monthly, Kisunla is th
Novo Nordisk's Weight Loss Drug Linked to Eye Disorder in Small Study
ADP Jobs Data, Constellation Brands, Summer Gas Prices: Morning Brief
Novo Nordisk Shares See Further Drop; 'Study Links Ozempic To Higher Risk Of Eye Condition That Can Cause Vision Loss' - STAT News
A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk's GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss.After hearing
Goldman Sachs raised the target price of Eli Lilly and Co. to $793.
On July 3rd, Goldman Sachs raised the target price of Eli Lilly and Co from $785 to $793 and maintained a "neutral" rating.
'Potential Link Between Ozempic, Wegovy And Serious Eye Condition Revealed In New Study' - New York Post
Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss.The risk of developing nonarteritic anterior ischemic optic neurop
Top 3 Health Care Stocks That May Crash This Quarter
As of July 3, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,041
Jefferies analyst Akash Tewari maintains $Eli Lilly and Co(LLY.US)$ with a buy rating, and adjusts the target price from $1,015 to $1,041.According to TipRanks data, the analyst has a success rate of
Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
Evercore analyst Umer Raffat maintains $Eli Lilly and Co(LLY.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average return of -8.8% over the pa
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,001 to $1,041
On Jul 03, major Wall Street analysts update their ratings for $Eli Lilly and Co(LLY.US)$, with price targets ranging from $1,001 to $1,041.Morgan Stanley analyst Terence Flynn maintains with a buy ra
Today's Analyst Rating | Microsoft Price Target Raised to $480 by Raymond James, Itau Unibanco Upgrades Apple to Hold
Jul 3, Wall Street analysts have updated their stock ratings today including $Microsoft(MSFT.US)$ and $Apple(AAPL.US)$.
BMO Capital Maintains Outperform on Eli Lilly and Co, Maintains $1001 Price Target
BMO Capital analyst Evan Seigerman maintains Eli Lilly and Co (NYSE:LLY) with a Outperform and maintains $1001 price target.
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Nvidia Is Starting to Act Like Its Own Asset Class
By Joseph Adinolfi Correlation between shares of the chip designer and the average S&P 500 stock hits lowest level in at least 10 years Shares of Nvidia Corp. are growing increasingly disconnected f
Stocks Edge Up Pre-Bell Ahead of Several Key Economic Reports; Asia, Europe Rise
US equity markets were pointing marginally higher in Wednesday's premarket activity as traders await the minutes of the Federal Reserve's latest policy meeting, as well as the release of several key e